نتائج البحث - "Bastian von Tresckow"

1

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

المساهمون: Hematology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life

المصدر: The Lancet Oncology, 22(2), 223-234. Lancet Publishing Group
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045Test(20)30601-X
Strahlentherapie Und Onkologie

مصطلحات موضوعية: Male, medicine.medical_treatment, Medizin, Procarbazine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, 030212 general & internal medicine, 610 Medicine & health, Etoposide, education.field_of_study, Middle Aged, Combined Modality Therapy, Hodgkin Disease, Dacarbazine, Treatment Outcome, Oncology, Vincristine, 030220 oncology & carcinogenesis, Female, Rituximab, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Population, Vinblastine, Disease-Free Survival, Bleomycin, Young Adult, 03 medical and health sciences, Internal medicine, Mucositis, Humans, education, Cyclophosphamide, Neoplasm Staging, Proportional Hazards Models, Chemotherapy, business.industry, medicine.disease, Regimen, ABVD, Doxorubicin, Positron-Emission Tomography, Prednisone, business, Literatur Kommentiert

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f13d466acfe65ac8d5c77ff231c4382Test
https://doi.org/10.1016/s1470-2045Test(20)30601-x

2

Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study : A report from the German Hodgkin Study Group

المؤلفون: Peter Borchmann, Andreas Rosenwald, Ina Bühnen, Martin-Leo Hansmann, Wolfram Klapper, Bastian von Tresckow, Andreas Engert, Michael Fuchs, Peter Möller, Dennis A. Eichenauer, Helen Goergen, Sylvia Hartmann, Alfred C. Feller, Stefanie Kreissl, Heinz-Wolfram Bernd

وصف الملف: application/octet-stream

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8abdc45b77ad5760367b866ffb7ef522Test
https://www.ncbi.nlm.nih.gov/pubmed/34396513Test

3

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

المؤلفون: Peter Borchmann, Richard Greil, Volker Diehl, Josée M. Zijlstra, Jana Markova, Julia Meissner, Sarah Gillessen, Andreas Engert, Max S. Topp, Annette Plütschow, Dennis A. Eichenauer, Bastian von Tresckow, Michael Fuchs, Paul J Bröckelmann

المساهمون: Hematology, CCA - Cancer Treatment and quality of life

المصدر: Gillessen, S, Plütschow, A, Fuchs, M, Markova, J, Greil, R, Topp, M S, Meissner, J, Zijlstra, J M, Eichenauer, D A, Bröckelmann, P J, Diehl, V, Borchmann, P, Engert, A & von Tresckow, B 2021, ' Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14) ', The Lancet Haematology, vol. 8, no. 4, pp. e278-e288 . https://doi.org/10.1016/S2352-3026Test(21)00029-6
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cfeea8e46362c19db45e3507629e0bTest
https://research.vumc.nl/en/publications/c1e461ac-5125-4d24-8c7e-10b59a9ac174Test

4

Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP

المصدر: Leukemia
Leukemia, 35(12):35893593

مصطلحات موضوعية: 0301 basic medicine, BEACOPP, Oncology, Male, Cancer Research, Receptor, Platelet-Derived Growth Factor alpha, Letter, CD30, medicine.medical_treatment, Medizin, 610 Medizin, 0302 clinical medicine, Gene expression, Antineoplastic Combined Chemotherapy Protocols, polycyclic compounds, Cancer microenvironment, Hodgkin lymphoma, Etoposide, ddc:610, Hematology, Middle Aged, Hodgkin Disease, Survival Rate, Treatment Outcome, Vincristine, 030220 oncology & carcinogenesis, Cohort, Female, Risk assessment, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Ki-1 Antigen, macromolecular substances, PDGFRA, 03 medical and health sciences, Bleomycin, Young Adult, Predictive Value of Tests, Internal medicine, medicine, Humans, Cyclophosphamide, Neoplasm Staging, business.industry, Gene Expression Profiling, Gene expression profiling, 030104 developmental biology, ABVD, Doxorubicin, Procarbazine, Prednisone, Chemokine CCL17, business, Transcriptome

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad6c3d13abb506896b7cd2eaa18a823Test
https://pubmed.ncbi.nlm.nih.gov/34112956Test

5

Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy

المؤلفون: Horst Müller, Bastian von Tresckow, Paul J Bröckelmann, Karolin Behringer, Michael Fuchs, Christian Baues, Peter Borchmann, Tom Vieler, Andreas Engert, Thomas Pabst, Alden A. Moccia, Martin Soekler, Andreas Rank, Teresa Guhl

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(2)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Disease, Vinblastine, 03 medical and health sciences, High dose chemotherapy, Bleomycin, Young Adult, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Progression-free survival, Stage (cooking), Young adult, 610 Medicine & health, Cyclophosphamide, Favorable Hodgkin Lymphoma, Aged, Etoposide, Neoplasm Staging, Proportional Hazards Models, Randomized Controlled Trials as Topic, Aged, 80 and over, business.industry, Proportional hazards model, Middle Aged, Hodgkin Disease, Progression-Free Survival, Dacarbazine, Treatment Outcome, Doxorubicin, Vincristine, 030220 oncology & carcinogenesis, Procarbazine, Prednisone, Disease characteristics, Female, business, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411db2afb7fa54bbe7a1f2de5a1dc20aTest
https://pubmed.ncbi.nlm.nih.gov/34478157Test

6

Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma:Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group

المساهمون: CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, Hematology

المصدر: Fuchs, M, Goergen, H, Kobe, C, Kuhnert, G, Lohri, A, Greil, R, Sasse, S, Topp, M S, Schäfer, E, Hertenstein, B, Soekler, M, Vogelhuber, M, Zijlstra, J M, Keller, U B, Krause, S W, Wilhelm, M, Maschmeyer, G, Thiemer, J, Dührsen, U, Meissner, J, Viardot, A, Eich, H, Baues, C, Diehl, V, Rosenwald, A, Von Tresckow, B, Dietlein, M, Borchmann, P & Engert, A 2019, ' Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma : Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group ', Journal of Clinical Oncology, vol. 37, no. 31, pp. 2835-2845 . https://doi.org/10.1200/JCO.19.00964Test
Journal of Clinical Oncology, 37(31), 2835-2845. American Society of Clinical Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa469fe12172ec2dda9ea09d53492d2Test
https://research.vumc.nl/en/publications/79c66fe8-a87f-4981-8d5b-ffffc8af5736Test

7

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial

المؤلفون: Martin Vogelhuber, Boris Böll, Martin Sökler, Michael Pfreundschuh, Peter Borchmann, Michael Fuchs, Indra Thielen, Carolin Bürkle, Bastian von Tresckow, Dennis A. Eichenauer, Annette Plütschow, Michaela Feuring-Buske, Andreas Engert, Johannes Atta

المصدر: British journal of haematology. 185(1)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeacb1f1259b2f1a20216c4b6be9c35aTest
https://pubmed.ncbi.nlm.nih.gov/30592027Test

8

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials

المؤلفون: Andrea Kerkhoff, Peter Borchmann, Bastian von Tresckow, Felicitas Hitz, Paul J Bröckelmann, Karolin Behringer, Richard Greil, Sven Borchmann, Carolin Bürkle, Andreas Engert, Helen Goergen, Michael Fuchs, Dennis A. Eichenauer, Volker Diehl, Boris Böll

المصدر: Blood. 127:2189-2192

مصطلحات موضوعية: Adult, Lung Diseases, Male, medicine.medical_specialty, Pulmonary toxicity, Dacarbazine, medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Vinblastine, Bleomycin, Biochemistry, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Adverse effect, Aged, Neoplasm Staging, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Remission Induction, Age Factors, Cell Biology, Hematology, Middle Aged, Hodgkin Disease, Chemotherapy regimen, Surgery, chemistry, ABVD, Doxorubicin, 030220 oncology & carcinogenesis, Female, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc788581949a2503fd80dd2ea227e7c0Test
https://doi.org/10.1182/blood-2015-11-681064Test

9

Outcome of patients with early-stage infradiaphragmatic hodgkin lymphoma: A comprehensive analysis from the German hodgkin study group

المؤلفون: Andreas Engert, Dennis A. Eichenauer, Peter Borchmann, Helen Goergen, Andreas Neubauer, Karolin Behringer, Christian Baues, Jana Markova, Michael Fuchs, Bastian von Tresckow, Max S. Topp, Stephanie Sasse, Annette Plütschow, Josée M. Zijlstra, Boris Böll, Richard Greil, Julia Meissner

المساهمون: Hematology, CCA - Cancer Treatment and quality of life

المصدر: Sasse, S, Goergen, H, Plütschow, A, Böll, B, Eichenauer, D A, Fuchs, M, Behringer, K, Zijlstra, J M, Greil, R, Markova, J, Topp, M S, Meissner, J, Neubauer, A, Baues, C, Engert, A, Borchmann, P & von Tresckow, B 2018, ' Outcome of patients with early-stage infradiaphragmatic hodgkin lymphoma: A comprehensive analysis from the German hodgkin study group ', Journal of Clinical Oncology, vol. 36, no. 25, pp. 2603-2611 . https://doi.org/10.1200/JCO.2018.78.7192Test
Journal of Clinical Oncology, 36(25), 2603-2611. American Society of Clinical Oncology

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, Kaplan-Meier Estimate, Disease, Bleomycin, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Cox proportional hazards regression, Overall survival, Humans, Medicine, In patient, Stage (cooking), Risk factor, Cyclophosphamide, Aged, Etoposide, business.industry, Chemoradiotherapy, Middle Aged, Hodgkin Disease, Progression-Free Survival, Dacarbazine, Clinical trial, Treatment Outcome, Doxorubicin, Vincristine, Lymphatic Metastasis, Procarbazine, 030220 oncology & carcinogenesis, Prednisone, Hodgkin lymphoma, Female, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d16f665b544bba1df6f10a89269f240Test
https://research.vumc.nl/en/publications/0c5dc4aa-a7b2-41ec-a2eb-67ae3298a489Test

10

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma

المؤلفون: Corinne Brillant, Andrea Will, Ina Monsef, Nicole Skoetz, Andreas Engert, Bastian von Tresckow

المصدر: The Cochrane Library

مصطلحات موضوعية: Medicine General & Introductory Medical Sciences, Oncology, BEACOPP, Adult, medicine.medical_specialty, Adolescent, Dacarbazine, medicine.medical_treatment, Procarbazine, Vinblastine, 03 medical and health sciences, Bleomycin, Young Adult, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Cyclophosphamide, Etoposide, Randomized Controlled Trials as Topic, business.industry, Hazard ratio, Middle Aged, Hodgkin Disease, Surgery, Regimen, ABVD, Doxorubicin, Vincristine, 030220 oncology & carcinogenesis, Meta-analysis, Relative risk, Disease Progression, Prednisone, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a64ffe7bb332a81db726723ef235d3Test
https://pubmed.ncbi.nlm.nih.gov/21833963Test

تنقيح النتائج